Advanced Therapies Week 2027
Advanced Therapies Week 2027 takes place on 19–21 January 2027 at San Diego Convention Center, San Diego. It is organised by Phacilitate, and B2DB lists 145 speakers and 245 sessions announced so far.
Advanced Therapies Week, organised by Phacilitate, takes place from 18 to 21 January 2027 in San Diego, California, and brings together cell and gene therapy professionals from research, therapeutic development and advanced manufacturing. The first day (Investment Summit) is held at the Hilton San Diego Bayfront, with the main programme from 19 to 21 January at the San Diego Convention Center.
Key facts
| Dates | 19–21 January 2027 (upcoming) |
|---|---|
| Venue | San Diego Convention Center, San Diego, United States of America |
| Organiser | Phacilitate |
| Series | Advanced Therapies Week |
| Speakers | 145 |
| Sessions | 245 |
| Stages | Investment Summit, Founders Forum, Workshop, Plenary, Phacilitate Stage, Commercializing Advanced Therapies, Innovation in Gene Delivery, Manufacturing, CMC and Supply Chain, Streamlining Early Development to Enable Rapid Clinical Proof of Concept, Innovation Zone, CGT Connect, Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation), Roundtables, Mezzanine Level, Women in Advanced Therapies |
| Sponsors | 36 |
| Official site | phacilitate.com/advanced-therapies-week/atw-2027-agenda |
Keynote speakers
- Yoshiaki Maruyama Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- Peter Marks Senior Vice President of Molecule Discovery & Head of Infectious Disease, Eli Lilly and Company
- Phung Osborn Vice President and Head of Global Market Access, Cell Therapy, Bristol Myers Squibb
- Scott Gottlieb Partner, New Enterprise Associates
- Steven Oh Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER, US Food & Drug Administration
Speakers (145)
Compiled from the published agenda; speakers can claim and verify their own entry.
- Yoshiaki Maruyama Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- Peter Marks Senior Vice President of Molecule Discovery & Head of Infectious Disease, Eli Lilly and Company
- Phung Osborn Vice President and Head of Global Market Access, Cell Therapy, Bristol Myers Squibb
- Scott Gottlieb Partner, New Enterprise Associates
- Steven Oh Director, Office of Cellular Therapy and Human Tissue, Office of Therapeutic Products, CBER, US Food & Drug Administration
- Raphael Ognar President & CEO, Co-founder, NKILT Therapeutics Inc.
- Sven Kili Partner, Saisei Ventures
- Thomas Eaton CEO and co-Founder of Limula, Limula
- Miguel Forte CEO, Kiji Therapeutics and Immediate Past President, International Society of Cell and Gene Therapy, Kiji Therapeutics
- Samar Mohanty President & CSO, Nanoscope Therapeutics
- Benjamin McLeod Founder, Convey Bio
- Mark Kay Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy, Stanford University
- Aaron Edwards CEO and Co-Founder, KiraGen Bio
- Boro Dropulić Executive Director, Caring Cross; CEO, Vector BioMed
- Cristina Salado Manzano Assistant Professor, Universitat Pompeu Fabra
- Damian Marshall VP - Analytical Development, Resolution Therapeutics
- Dhruv Sareen Founding Director, (IPSC) Core Facility, Cedars-Sinai & Founding Executive Director, Cedars-Sinai Biomanufacturing Center
- Gina Jiang Managing Director, Hong Kong Institute of Biotechnology
- Jeanne Loring Professor Emeritus, Scripps Research
- Jeroen de Vrij CEO, ExoVectory
- Kate Excoffon American Society for Gene and Cell Therapy, American Society of Gene & Cell Therapy
- Lindsey MacDonald Manager of CCTTs Data Analytics Unit, University of Pennsylvania Health System, Penn Medicine
- Mamta Kalra Vice President Process and Analytical Development, Immatics
- Mercedes Segura Gally VP Process Development, Editas Medicine
- Nelly Viseux VP Cell Therapies Development, Manufacturing Supply & Quality, Regeneron Pharmaceuticals
- Sheena Smith Assistant Professor of Biotechnology, School of Chemistry, Chemical Engineering and Biotechnology (CCEB), Nanyang Technological University, Singapore
- Snehal Naik Vice President, Science and Regulatory, BIO
- Vivian Choi Vice President, Liver Programs and Nonclinical Development, Prime Medicine, Inc.
- Yisrael Katz Founder, Blue Marble Network
- Zoya Gluzman-Poltorak CEO and Co-Founder, Forta Bio
- Aishwarya Shevade Senior Staff Engineer, Analytical Development, Regeneron Pharmaceuticals
- Ashish Saksule Associate Director, Vertex Pharmaceuticals
- Caryl Harris Co-Founder and Executive Director, Avery's Hope
- Chris Juenger Director, Lead, North America Regulatory Science, Policy and Intelligence, CSL
- Deborah Hursh Consultant, Hursh Cell Therapy Consulting
- Eugene Jiaxian Wang Founder & CEO, HELP Therapeutics
- Greg Russotti Chief Technology & Manufacturing Officer, Century Therapeutics
- Gregory Whitehead Executive Vice President & Chief Technical & Quality Officer, Editas Medicine
- Jason Beckwith Leader in Residence, University of Leeds
- Jeffrey Cram Vice President of Process Development, Elevatebio
- Jillian Arnold Speaker, Author, Podcast Host, Advocate, Confessions of a Rare Disease Mama
- Kirsten Vonde Principal Consultant, Granzer Regulatory Consulting & Services GmbH
- Kyle Carter Senior Director, Quality, Data Systems and Data Processes, Kite Pharma
- Liangfang Zhang Joan and Irwin Jacobs Chancellor Professor & Chair, Aiiso Family Department of Chemical and Nano Engineering, Jacobs School of Engineering, University of California San Diego
- Michael Klichinsky CSO, Nava Therapeutics
- Nathalie Clément Senior Vice President, Vector Development, Siren Biotechnology
- Peter Webster Associate Director of Analytical Science and Technology (AS&T), Solid Bio
- Samik Basu CSO, Cabaletta Bio
- Sarah Yuan Chief Technology Officer, Cabaletta Bio
- Sooraj Achar CSO, Akimbo Bio
- Adam Fung Sr Director, Global Product Quality, Iovance Biotherapeutics
- Adi Braun Senior Director, Apheresis and Infusion Operations, Autolus Therapeutics
- Alan Moazzam Health Sciences Associate Clinical Professor, UC San Diego Health
- Alejandra Gutierrez Guerrero Product Manager, Cell Therapy Biomaterial, Grifols Bio Supplies
- Alexey Bersenev Director Advanced Cell Therapy Lab, Yale University
- Alison Burkart Director, Astellas Pharma
- Angela Pietrofeso Vice President Clinical Operations, Boundless Bio
- Ayman Elguindy CEO and Cofounder, AbVir Biotherapeutics
- Basak Clements Founder & Senior Scientific Advisor, biomatria
- Bella Neufeld VP of Operations, Teknova
- Bonnie Nannenga-Combs DIrector, Sterne, Kessler, Goldstein & Fox
- Caitlin Cahill Administration Director, University of Pennsylvania Health Systems, Penn Medicine
- Cédric Cleyrat Executive Director, Head of Cell Therapy BioEngineering & Technology Innovation, Bristol Myers Squibb
- Chelsea Amstuz Associate Director, Vector Attribute Sciences, Bristol Myers Squibb
- Claudia Lee CTO, Velvet Therapeutics
- Craig Beasley Chief Technology Officer, BlueRock Therapeutics
- Dena Flamm Business Development Manager, OPTIMA packaging group GmbH
- Donna Rill Chief Technology Officer, Triumvira Immunologics
- Elina Lavit CEO / Chapter Chair, Women in Bio
- Erin Cross Vice President of Development, KROMATID
- Ignacio Willats Co-Founder & CCO, Mytos
- Isabel Tian Senior Director, Scientific Affairs, Cellares
- J. Rodrigo Mora CSO, BreezeBio
- Jack Florio Managing Director, IPL Capital Advisory
- Jacob Rosenberg VP Clinical Operations, Tr1X
- James Zanewicz CEO, CONNECT
- Jay Cuenca Executive Director, Manufacturing and Plant Manager, Allogene Therapeutics
- Jeff Friedman Managing Partner, Friedman Bioventure
- Jeff Liter CEO and President, Luminary Therapeutics
- Jeffrey Graybill Vice President, CMC Commercial Strategy, Immatics
- Jerry Jiang Vice President, Global Sales, CellBri
- Joanna Ghayad CEO, Founder, Executive Coach, Joanna Ghayad Coaching
- Josh Sorafine Senior Vice President Quality and Analytics, Editas Medicine
- Justin Shakespeare Vice President Global Portfolio & Asset Commercialisation Strategy, Kite Pharma
- Katy Barglow CTO, 4D Molecular Therapeutics
- Kelsey Wakley-Sharman Director of Operations - Cell & Gene Therapies, QuickSTAT
- Kim Raineri Chief Technology Officer, Aspen Neuroscience
- Louis Cicchini Senior Director Scientific Affairs and CGT Partnerships, Cencora
- Margherita Neri Senior Director, GMP Manufacturing, AGC Biologics
- Maria Grazia Roncarolo Co-founder, President and Head of R&D, Tr1x Bio
- Mary Hames Board Member, CURE NDD
- Meena Narayanan Senior Scientist - Process Analytics, Genentech
- Michalle Adkins Director of Life Sciences Strategy and Communications, Emerson
- Misti Cain Executive Producer & Host, The Pitch
- Mohammad Sayed Cofounder & CTO, Telos Biotechnology
- Mya Thu Co-founder and CEO, VisiCELL Medical
- Natalia Elizalde Chief Business Development Officer, VIVEbiotech
- Nicholas Crudele Producer, Out of the lab: Operationalizing cell and gene therapy
- Nikki Bishop Vice President of Marketing & Exoerience, Emerson
- Noah Davidsohn CSO and Co-founder, Rejuvenate Bio
- Nolan Polson Vice President, Quality Assurance & Product Quality, Iovance Biotherapeutics, Inc.
- Ohad Karnieli Adva Biotechnology
- Peter He Co-Founder & Chief Scientific Officer, OriCell Therapeutics
- Raj Krishnan CEO and Founder, Stealth Biotech Startup
- Randy Berholtz Senior Advisor, Mesa Verde Venture Partners
- Rocio Manghani Vice President of Market Access, Allogene Therapeutics
- Rohin Iyer Senior Director, Global Cell and Gene Therapy Operations, Marken
- Romuald Corbau CSO, Capsida Biotherapeutics
- Shesh Sharma Managing Partner, Innolynx Inc.
- Srinivas Chollangi Executive Director, CMC Tech Operations, Stylus Medicine
- Susan Nichols Chief Executive Officer, Propel Biosciences
- Tatiana Nanda CTO, SK Pharmteco
- Therese Choquette CTO, Tigen Pharma
- Tunde Babalola Senior Vice President, Technical Operations & Quality, Fate Therapeutics
- Vasily Medvedev Chief Technology Officer, VVMF
- Vilma Methner Senior Market Development Manager - ATMP, OPTIMA packaging group GmbH
- Xavier de Mollerat du Jeu Global Head of Automation, Legend Biotech
- Amelia Heesen Field Application Specialist, Cell & Gene Therapy Technologies, Fresenius Kabi
- Amit Joshi Senior Director, Strategic Sourcing, Iovance Biotherapeutics
- Ben Comer Chief Editor and Host, Life Science Leader, Business of Biotech
- Carlos Candido Vice President, Cell Therapy Operations, Eledon Pharmaceuticals
- Claire Gueguen R&D Life Sciences Manager, Sartorius
- George Eastwood Executive Director, Emily Whitehead Foundation
- Irene Rombel CEO and Co-Founder, BioCurie
- Jianhua Feng Director, Department of Pediatrics, Zhejiang University School of Medicine
- Jin Yin CTO, ProBio
- Lili Belcastro Associate Director, Bristol Myers Squibb
- Nicholas Boyd Head of Biology, Applications & Validation, Celleo
- Noelle Harff Technology and Biotech Reporter, San Diego Union-Tribune
- Rok Sekirnik Head of Process Development for mRNA and pDNA, Sartorius
- Steven Falcone COO, Elevatebio
- Tracy Ryan Advisory Board, Head of Communications & Patient Relations, CellxLife
- Adrienne B. Mendoza Chief Operating Officer, BBG Advanced Therapies
- Ahmed Mousa General Manager, Lafana
- Amanda Conerty Executive Director, Head of Produce Operations, Artiva Biotherapeutics
- Andrea Penn Senior Director, Commercial Learning and Development, Autolus
- Jimi Olaghere Patient Advocate
- Julia Rohlhill Associate Director, Viral Vector Sciences, Legend Biotech
- Laurie Adami Patient Advocate
- Madelyn Fell Director of Operations, Cell Therapy and Transplant, University of Pennsylvania Health System, Penn Medicine
- Michael E. Meyers Vice Chairman, Head of M&A, Credit & Royalty Finance, H.C. Wainwright & Co., LLC
- Ronit Slotky Director, Cell Therapies Manufacturing Facility, Hackensack University Medical Center
- Sybil Danby VP, Business Development and Strategy, Asimov
- Tony Busby Account Manager, Legend Biotech Ireland Plc
- Tori Lee Program Assistant, American Association for Cancer Research (AACR)
Most represented companies
- Bristol Myers Squibb — 4 speakers
- Editas Medicine — 3 speakers
- Allogene Therapeutics — 2 speakers
- Cabaletta Bio — 2 speakers
- Elevatebio — 2 speakers
- Emerson — 2 speakers
- Immatics — 2 speakers
- Iovance Biotherapeutics — 2 speakers
- Kite Pharma — 2 speakers
- Legend Biotech — 2 speakers
Agenda (245 sessions)
Day 1 — Monday 18 January 2027
- Investment Summit 09:00–12:00 · Investment Summit — Sven Kili, Yisrael Katz, Alan Moazzam, Jack Florio +4 more
- Opening - The new capital map: Where is the money actually moving in CGT 09:00–09:10 · Investment Summit — James Zanewicz, Misti Cain
- Panel: Where is the next wave of investment going? 09:10–09:50 · Investment Summit — Sven Kili, Jack Florio, Randy Berholtz
- Panel: Beyond VC - Alternative funding models for biotech 09:50–10:30 · Investment Summit — Yisrael Katz, Alan Moazzam
- Ask the Investors: Your questions, Their answers 11:00–12:00 · Investment Summit — Sven Kili, Jeff Friedman
- Opening panel: From scientist to CEO: The identity shift noone prepares you for 13:00–13:30 · Founders Forum — Jeanne Loring, Zoya Gluzman-Poltorak
- China IIT workshop 13:00–16:00 · Workshop — Eugene Jiaxian Wang, Jianhua Feng
- Founders Forum 13:00–16:00 · Founders Forum — Jeanne Loring, Yisrael Katz, Zoya Gluzman-Poltorak, Angela Pietrofeso +4 more
- Workshop 1: ARMI | BioFabUSA 13:30–14:30 · Founders Forum
- Workshop 2: Cell & gene development pitfalls 14:30–15:15 · Founders Forum — Yisrael Katz, Angela Pietrofeso, Ayman Elguindy, Raj Krishnan
- Workshop 3: Beyond the pitch: What first-time founders don't see comig after the first meeting 15:15–16:00 · Founders Forum — Joanna Ghayad
- Patient Plenary 16:15–17:15 · Plenary — Caryl Harris, Jillian Arnold
- Fireside chat: Caryl Harris 16:15–16:35 · Plenary — Caryl Harris
- Fireside chat: Jillian Arnold 16:35–16:55 · Plenary — Jillian Arnold
- Fireside chat: Derek Nesbit 16:55–17:15 · Plenary
Day 2 — Tuesday 19 January 2027
- Workshop: ThermoFisher 08:00–09:00 · Workshop
- Phacilitate TV: Interview 1 09:00–09:30 · Phacilitate Stage
- Plenary: How must healthcare and industry models evolve to achieve the elusive goal of improved patient access? 09:00–10:30 · Plenary — Peter Marks, Phung Osborn, Scott Gottlieb, Susan Nichols +1 more
- Phacilitate TV part 1 09:00–10:30 · Phacilitate Stage — Benjamin McLeod
- Top 5 trends for 2027 09:05–09:20 · Plenary — Susan Nichols
- Keynote industry perspective 09:20–09:40 · Plenary — Phung Osborn
- Phacilitate TV: Interview 2 09:30–10:00 · Phacilitate Stage
- Keynote Discussion Integrating product delivery and market access for the next generation of cell & gene therapies 09:40–10:30 · Plenary — Peter Marks, Scott Gottlieb
- Phacilitate TV: Interview 3 10:00–10:30 · Phacilitate Stage
- Phacilitate TV: Interview 4 10:30–11:00 · Phacilitate Stage
- Panel: Where do cell and gene therapies fit in the future cancer treatment landscape? 11:00–11:30 · Commercializing Advanced Therapies — Justin Shakespeare
- Spotlight/Fireside Chat 11:00–11:15 · Innovation in Gene Delivery
- Spotlight: Building reliable, scalable and cost-efficient TCR-T manufacturing 11:00–11:15 · Manufacturing, CMC and Supply Chain — Mamta Kalra
- Spotlight 11:00–11:15 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Nelly Viseux
- Session 1: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialisation? Part 1 11:00–12:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Nelly Viseux, Meena Narayanan, Ohad Karnieli, Vasily Medvedev
- Session 1: Where will cell & gene therapies sit in the cancer armamentarium of the future? 11:00–12:00 · Commercializing Advanced Therapies — Miguel Forte, Justin Shakespeare
- Session 1: How are key gene delivery platforms stacking up both in vivo and ex vivo to address concerns around safety, immunogenicity, durability, efficacy, and redosing potential? 11:00–12:00 · Innovation in Gene Delivery — Mark Kay, Kate Excoffon, Mercedes Segura Gally
- Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency? 11:00–12:00 · Manufacturing, CMC and Supply Chain — Mamta Kalra, Greg Russotti, Jeffrey Cram, Sarah Yuan +1 more
- Spotlight 11:15–11:30 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Ohad Karnieli
- Spotlight: Automating your way to regulatory confidence: a comparability Case Study 11:15–11:30 · Manufacturing, CMC and Supply Chain — Isabel Tian
- Live podcast: Confessions of a rare disease mama 11:15–12:00 · Phacilitate Stage — Caryl Harris, Jillian Arnold
- Spotlight/Fireside Chat 11:15–11:30 · Innovation in Gene Delivery
- Spotlight: Can the production of iPSC-derived beta islets for Type I diabetes be scaled up to be commercially viable? 11:30–11:45 · Manufacturing, CMC and Supply Chain — Greg Russotti
- Panel: Building a scalable early-development strategy: Selecting platforms and tools that enable rapid clinical proof of concept 11:30–12:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Meena Narayanan, Vasily Medvedev
- Panel discussion: What is the data telling us about the clinical pathway to safe and efficacious in vivo gene therapy products? 11:30–12:00 · Innovation in Gene Delivery — Mark Kay, Kate Excoffon, Mercedes Segura Gally
- Spotlight: From complex to cost-effective: De-risking cell therapy manufacturing with automation and in vivo capabilities 11:45–12:00 · Manufacturing, CMC and Supply Chain — Jeffrey Cram
- Presentation 1 12:00–12:10 · Innovation Zone
- Regulator drop in 12:00–13:00 · CGT Connect — Chris Juenger, Deborah Hursh, Kirsten Vonde
- Session 2: Non-viral delivery Part 1 - R&D and Regulatory focus 12:00–13:00 · Innovation in Gene Delivery — Jeroen de Vrij, Liangfang Zhang, J. Rodrigo Mora
- Innovation zone: Enabling technology & tools 12:00–13:00 · Innovation Zone
- Session 1: Referral & Awareness 12:00–13:00 · Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
- Spotlight: Cellular nanoparticles for drug and gene delivery 12:00–12:15 · Innovation in Gene Delivery — Liangfang Zhang
- Session 2: Innovation in viral vector manufacturing 12:00–13:00 · Manufacturing, CMC and Supply Chain — Ashish Saksule, Margherita Neri
- Spotlight/Fireside Chat 12:00–12:15 · Manufacturing, CMC and Supply Chain
- Presentation 2 12:10–12:20 · Innovation Zone
- Spotlight/Fireside Chat 12:15–12:30 · Innovation in Gene Delivery
- Phacilitate hub meet up: How to turn clinical success into commercial success 12:15–13:00 · Commercializing Advanced Therapies
- Spotlight: Can we manufacture in vivo gene therapies at commercial scale? 12:15–12:30 · Manufacturing, CMC and Supply Chain — Margherita Neri
- Presentation 3 12:20–12:30 · Innovation Zone
- Presentation 4 12:30–12:40 · Innovation Zone
- Panel discussion 12:30–13:00 · Innovation in Gene Delivery — Jeroen de Vrij, Liangfang Zhang, J. Rodrigo Mora
- Spotlight/Fireside Chat 12:30–12:45 · Manufacturing, CMC and Supply Chain
- Presentation 5 12:40–12:50 · Innovation Zone
- Spotlight 12:45–13:00 · Manufacturing, CMC and Supply Chain
- Presentation 6 12:50–13:00 · Innovation Zone
- Workshop: Cytiva 12:55–13:55 · Workshop
- The Big Debate: In vivo CAR-T - is it the future or just more hype? 13:00–14:00 · Phacilitate Stage — Michael Klichinsky
- Workshop: Cellular Origins 13:15–14:15 · Workshop
- Session 3: Non-viral delivery Part 2 - Manufacturing, CMC and supply chain focus 14:00–15:00 · Innovation in Gene Delivery — Srinivas Chollangi
- Meet the CRO 14:00–15:00 · CGT Connect
- Phacilitate TV part 2 14:00–15:00 · Phacilitate Stage — Benjamin McLeod
- Session 2: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialization? Part 2 14:00–15:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Damian Marshall, Mamta Kalra, Josh Sorafine
- Phacilitate hub meet up: When is the right time for biotech too pursue a processing technology platform 14:00–15:00 · Manufacturing, CMC and Supply Chain
- Fireside Chat: Autoimmune CGT development and safety pathway ' What success actually requires 14:00–14:15 · Commercializing Advanced Therapies
- Innovation zone: Delivery, targeting & in vivo technologies 14:00–15:00 · Innovation Zone — Natalia Elizalde
- Session 2: Advanced therapy products for autoimmune diseases 14:00–15:00 · Commercializing Advanced Therapies — Samik Basu, Jeff Liter, Maria Grazia Roncarolo
- Phacilitate TV: Interview 5 14:00–14:30 · Phacilitate Stage
- Spotlight 14:00–14:15 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Damian Marshall
- Fireside Chat 14:00–14:15 · Innovation in Gene Delivery — Srinivas Chollangi
- Presentation 7 14:00–14:10 · Innovation Zone — Natalia Elizalde
- Presentation 8 14:10–14:20 · Innovation Zone
- Spotlight 14:15–14:30 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept
- Spotlight 14:15–14:30 · Commercializing Advanced Therapies
- Spotlight: Rare disease trial innovation 14:15–14:30 · Commercializing Advanced Therapies — Kirsten Vonde
- Spotlight 14:15–14:30 · Innovation in Gene Delivery
- Presentation 9 14:20–14:30 · Innovation Zone
- Presentation 10 14:30–14:40 · Innovation Zone
- Panel: The benchtop bottleneck: Solving the scalable processing shortage 14:30–15:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Mamta Kalra, Josh Sorafine
- Panel: Winning in autoimmune disease - Where CGTs can actually compete? 14:30–15:00 · Commercializing Advanced Therapies — Jeff Liter, Maria Grazia Roncarolo
- Panel discussion 14:30–15:00 · Innovation in Gene Delivery
- Phacilitate TV: Interview 6 14:30–15:00 · Phacilitate Stage
- Panel: Building a sustainable commercial future for rare and nano-rare advanced therapies 14:30–15:00 · Commercializing Advanced Therapies — Samar Mohanty, Mary Hames
- Presentation 11 14:40–14:50 · Innovation Zone
- Presentation 12 14:50–15:00 · Innovation Zone
- Spotlight 15:00–15:15 · Manufacturing, CMC and Supply Chain — Dhruv Sareen
- Fireside Chat: Defining 'phase-appropriate' development: How much is enough to reach the clinic 15:00–15:15 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Adam Fung, Noah Davidsohn
- Session 2: Eligibility & Payer Authorization 15:00–16:00 · Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
- Session 3: What does ‘phase-appropriate’ actually look like in early process and product development? 15:00–16:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Adam Fung, Alison Burkart, Donna Rill, Noah Davidsohn +1 more
- AI Workshop 15:00–17:00 · CGT Connect — Jason Beckwith, Kyle Carter, Irene Rombel
- Session 3: iPSCs – what does the future hold? Part 1 15:00–16:00 · Manufacturing, CMC and Supply Chain — Dhruv Sareen, Jeanne Loring, Eugene Jiaxian Wang, Kim Raineri
- Live podcast: Business of biotech 15:15–16:00 · Phacilitate Stage — Ben Comer
- Spotlight/Fireside Chat 15:15–15:30 · Manufacturing, CMC and Supply Chain
- Spotlight 15:15–15:30 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Tatiana Nanda
- Panel discussion 15:30–16:00 · Manufacturing, CMC and Supply Chain — Jeanne Loring, Eugene Jiaxian Wang
- Panel: Beyond IND: Balancing early CMC decisions with long-term commercial success 15:30–16:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Alison Burkart, Donna Rill
- Fireside Chat 16:00–16:15 · Manufacturing, CMC and Supply Chain — Craig Beasley
- Session 3: How to ensure the long-term future of advanced therapies for rare, ultra-rare and nano-rare diseases? 16:00–17:00 · Commercializing Advanced Therapies — Samar Mohanty, Kirsten Vonde, Mary Hames
- Session 4: Genome and epigenome editing: troubleshooting the pathway to clinic and the marketplace beyond 16:00–17:00 · Innovation in Gene Delivery — Vivian Choi, Gregory Whitehead
- Innovation zone: Cell therapeutics developers 16:00–17:00 · Innovation Zone — Aaron Edwards, Claudia Lee, Elina Lavit
- Live podcast: Operational challenges in CGT drug development 16:00–16:45 · Phacilitate Stage — Basak Clements, Nicholas Crudele
- Session 4: iPSCs – what does the future hold? Part 2 16:00–17:00 · Manufacturing, CMC and Supply Chain — Dhruv Sareen, Craig Beasley, Ignacio Willats, Kim Raineri +1 more
- Fireside chat: Re-engineering development pathways for the rarest patients 16:00–16:15 · Commercializing Advanced Therapies
- Spotlight 16:00–16:15 · Innovation in Gene Delivery
- Presentation 13 16:00–16:10 · Innovation Zone — Aaron Edwards
- Presentation 14 16:10–16:20 · Innovation Zone — Claudia Lee
- Spotlight/Fireside Chat 16:15–16:30 · Innovation in Gene Delivery
- Spotlight 16:15–16:30 · Manufacturing, CMC and Supply Chain — Ignacio Willats
- Presentation 15 16:20–16:30 · Innovation Zone
- Panel discussion 16:30–17:00 · Manufacturing, CMC and Supply Chain — Dhruv Sareen, Tunde Babalola
- Panel discussion 16:30–17:00 · Innovation in Gene Delivery — Vivian Choi, Gregory Whitehead
- Presentation 16 16:30–16:40 · Innovation Zone
- Presentation 17 16:40–16:50 · Innovation Zone
- Presentation 18 16:50–17:00 · Innovation Zone — Elina Lavit
- Workshop: In Vivo CAR-T: Turning clinical promise into an IND-ready program 17:00–18:00 · Workshop — Jin Yin
- Workshop: Sartorius 17:10–18:10 · Workshop
Day 3 — Wednesday 20 January 2027
- Phacilitate TV: Interview 7 09:00–09:30 · Phacilitate Stage
- Plenary: Plotting a course to sustainable future success for the cell & gene therapy industry 09:00–10:20 · Plenary — Yoshiaki Maruyama, Steven Oh, Sven Kili, Samar Mohanty +4 more
- Keynote Regulatory Roundtable - perspectives on key areas of importance to the cell & gene therapy industry 09:00–09:30 · Plenary — Yoshiaki Maruyama, Steven Oh
- Phacilitate TV Part 3 09:00–11:00 · Phacilitate Stage — Benjamin McLeod
- Pharma roundtable 09:30–09:55 · Plenary — Nelly Viseux, Cédric Cleyrat
- Phacilitate TV: Interview 8 09:30–10:00 · Phacilitate Stage
- Roundtable discussion: The global picture 09:55–10:20 · Plenary — Samar Mohanty, Gina Jiang, Peter He
- Phacilitate TV: Interview 9 10:00–10:30 · Phacilitate Stage
- Phacilitate TV: Interview 10 10:30–11:00 · Phacilitate Stage
- Workshop: Beyond Viral Vectors: An End-to-End Platform for Rapid CAR-T and CAR-NK Generation 10:30–11:00 · Workshop — Claire Gueguen, Rok Sekirnik
- Workshop: From cell selection to fill-finish: Building connected cell therapy manufacturing workflows 10:30–11:00 · Workshop — Jeffrey Cram, Amelia Heesen, Nicholas Boyd
- CDMO strategy for the long term 11:00–12:00 · CGT Connect — Carlos Candido
- Spotlight: CAR-T supply chain: Precision logistics for high-volume delivery 11:00–11:15 · Commercializing Advanced Therapies — Rohin Iyer
- Spotlight: Beyond the Membrane: Mechanistic insights into differential transduction by AAV capsids 11:00–11:15 · Innovation in Gene Delivery — Mark Kay
- Session 4: What are the strategic and technological manufacturing and supply chain advances required to enable commercial CAR-T cell therapies to scale beyond 20% of eligible patients? 11:00–12:00 · Commercializing Advanced Therapies — Boro Dropulić, Lindsey MacDonald, Deborah Hursh, Caitlin Cahill +1 more
- Session 5: Viral Vectors - Innovation in AAV: Building the next generation of safe, scalable and affordable vector platforms 11:00–12:00 · Innovation in Gene Delivery — Mark Kay, Katy Barglow, Romuald Corbau
- Spotlight: Leveraging Prior Knowledge to Accelerate the Development of Multiple Liver-Directed Prime Editors 11:05–11:20 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Vivian Choi
- Session 4: How and where to harness NAMs in support of in vivo preclinical models in practice? Learning lessons from recent regulatory responses to IND applications 11:05–12:05 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Kate Excoffon, Vivian Choi
- Spotlight/Fireside Chat 11:15–11:30 · Innovation in Gene Delivery
- Live podcast with Ben and Jeff 11:15–12:00 · Phacilitate Stage — Benjamin McLeod
- Spotlight: You scaled the therapy - Can the health system scale with it? 11:15–11:30 · Commercializing Advanced Therapies — Lindsey MacDonald
- Spotlight 11:20–11:35 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept
- Panel discussion 11:30–12:00 · Innovation in Gene Delivery — Mark Kay, Katy Barglow, Romuald Corbau
- Panel: Designing the end-to-end CAR-T ecosystem: What it takes to treat the majority of patients 11:30–12:00 · Commercializing Advanced Therapies — Boro Dropulić, Deborah Hursh, Caitlin Cahill
- Panel: Integrating new approach methodologies into early development: Where do NAMs deliver the greatest value? 11:35–12:05 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Kate Excoffon
- How do you plan and execute successful overseas IIT in the APAC and Australian regions? 12:00–13:00 · CGT Connect — Yoshiaki Maruyama, Miguel Forte, Samar Mohanty
- Innovation zone: Clinical development & translational tools 12:00–13:00 · Innovation Zone — Mya Thu
- Session 5: Stepping back and reviewing the advanced therapy sector’s approach to automation 12:00–13:00 · Manufacturing, CMC and Supply Chain — Greg Russotti, Sarah Yuan, Dena Flamm, Jeffrey Graybill +2 more
- Phacilitate hub meet up: Navigating the complex IP landscape for delivery platforms 12:00–13:00 · Innovation in Gene Delivery
- Spotlight: Scaling CAR-T: lessons from a commercial manufacturing launch 12:00–12:15 · Manufacturing, CMC and Supply Chain — Xavier de Mollerat du Jeu
- Session 3: Site Readiness & Manufacturing Handoff 12:00–13:00 · Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
- Presentation 19 12:00–12:10 · Innovation Zone
- Presentation 20 12:10–12:20 · Innovation Zone — Mya Thu
- Spotlight: Flexible, automated platforms for next-generation CGT manufacturing 12:15–12:30 · Manufacturing, CMC and Supply Chain — Dena Flamm, Vilma Methner
- Presentation 21 12:20–12:30 · Innovation Zone
- Presentation 22 12:30–12:40 · Innovation Zone
- Spotlight: Scaling autologous CAR-T manufacturing for autoimmune patients 12:30–12:45 · Manufacturing, CMC and Supply Chain — Sarah Yuan
- Presentation 23 12:40–12:50 · Innovation Zone
- Spotlight: LIfe-cycle management of CGT manufacturing process - managing the evolution of a CGT manufacturing process to build in robustness, reduce risk, and manage COGS 12:45–13:00 · Manufacturing, CMC and Supply Chain — Jeffrey Graybill
- Presentation 24 12:50–13:00 · Innovation Zone
- Workshop: Invetech 13:00–14:00 · Workshop
- The Big Debate: Will AAV in vivo gene therapy still dominate in 2030? 13:00–13:45 · Phacilitate Stage
- Phacilitate hub meet up: How can developers accelerate the path to clinical proof of concept without making early decisions that compromise future scalability, regulatory readiness or commercial viability 14:00–15:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept
- Innovation zone: Gene therapeutic developers 14:00–15:00 · Innovation Zone
- Session 5: COGs control - how far do we still have to go, and what should be our key targets for further progress in reducing manufacturing and supply chain costs? 14:00–15:00 · Commercializing Advanced Therapies — Gregory Whitehead, Jerry Jiang, Michalle Adkins, Shesh Sharma
- Session 6: Cell therapy product characterization and QC 14:00–15:00 · Manufacturing, CMC and Supply Chain — Damian Marshall, Alejandra Gutierrez Guerrero, Erin Cross, Nolan Polson +2 more
- Session 6: Viral Vectors - Innovation in LVV: building the next generation of safe, scalable, and affordable vector platforms 14:00–15:00 · Innovation in Gene Delivery — Boro Dropulić, Nathalie Clément, Sooraj Achar
- Spotlight 14:00–14:15 · Innovation in Gene Delivery — Sooraj Achar
- Presentation 25 14:00–14:10 · Innovation Zone
- Spotlight: Cell therapy manufacturing re-engineered: Unlocking global access & scale out economics 14:00–14:15 · Commercializing Advanced Therapies — Jerry Jiang
- Spotlight: Concept and case studies for an enhanced analytical control strategy and practical execution for cell therapies 14:00–14:15 · Manufacturing, CMC and Supply Chain
- Phacilitate TV part 4 14:00–15:00 · Phacilitate Stage — Benjamin McLeod
- Phacilitate TV: Interview 11 14:00–14:30 · Phacilitate Stage
- Presentation 26 14:10–14:20 · Innovation Zone
- Spotlight 14:15–14:30 · Innovation in Gene Delivery — Boro Dropulić
- Spotlight: From cell sourcing to expansion: the role of quality-driven human raw materials in cell therapy 14:15–14:30 · Manufacturing, CMC and Supply Chain — Alejandra Gutierrez Guerrero
- Fireside Chat: TBC 14:15–14:30 · Commercializing Advanced Therapies
- Presentation 27 14:20–14:30 · Innovation Zone
- Panel: Cracking the COGs challenge: What must change to make CGTs truly scalable? 14:30–15:00 · Commercializing Advanced Therapies — Michalle Adkins, Shesh Sharma
- Panel discussion 14:30–15:00 · Manufacturing, CMC and Supply Chain — Damian Marshall, Erin Cross, Nolan Polson, Therese Choquette
- Presentation 28 14:30–14:40 · Innovation Zone
- Panel discussion 14:30–15:00 · Innovation in Gene Delivery — Sooraj Achar
- Phacilitate TV: Interview 12 14:30–15:00 · Phacilitate Stage
- Presentation 29 14:40–14:50 · Innovation Zone
- Presentation 30 14:50–15:00 · Innovation Zone
- Session 7: Gene therapy product characterization and QC 15:00–16:00 · Manufacturing, CMC and Supply Chain — Aishwarya Shevade, Chelsea Amstuz
- Roundtable: Bringing early-phase trials back to the US 15:00–16:00 · Roundtables — Snehal Naik
- Roundtable 15:00–16:00 · Roundtables — Bonnie Nannenga-Combs
- Roundtable: Responsibile use of AI manufacturing 15:00–16:00 · Roundtables — Nikki Bishop
- Roundtable Discussions 15:00–16:00 · Mezzanine Level — Cristina Salado Manzano, Lindsey MacDonald, Snehal Naik, Jason Beckwith +2 more
- Roundtable: Can your workforce deliver the therapy? Measuring capability for advanced therapies 15:00–16:00 · Roundtables — Jason Beckwith
- How to reduce the current fragility of cell & gene therapy raw materials supply chains? 15:00–17:00 · CGT Connect — Basak Clements, Amit Joshi, Lili Belcastro
- Roundtable: Cracking the EU Code: Turning regulatory & supply complexities into a smooth process 15:00–16:00 · Roundtables — Cristina Salado Manzano
- Roundtable: From referral to infusion: Digitally connecting manufacturers and treatment centres across the CAR-T journey 15:00–16:00 · Roundtables — Lindsey MacDonald
- Spotlight: Accelerating infectivity assay workflows for AAV with automation and AI-assisted data analysis 15:00–15:15 · Manufacturing, CMC and Supply Chain — Aishwarya Shevade
- Session 4: Infusion & Community Delivery 15:00–16:00 · Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
- Spotlight/Fireside Chat 15:15–15:30 · Manufacturing, CMC and Supply Chain
- Live podcast: Operational challenges in CGT drug development 15:15–16:00 · Phacilitate Stage — Nicholas Crudele
- Panel discussion 15:30–16:00 · Manufacturing, CMC and Supply Chain — Aishwarya Shevade, Chelsea Amstuz
- Presentation 31 16:00–16:10 · Innovation Zone — Thomas Eaton
- Session 6: Supply chain as a commercial strategy 16:00–17:00 · Commercializing Advanced Therapies — Cristina Salado Manzano, Adi Braun, Alexey Bersenev, Bella Neufeld +1 more
- Session 5: Innovation in early clinical trial design and execution: how to streamline the pathway to rapid clinical proof of concept while avoiding the pitfalls? 16:00–17:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Samar Mohanty, Zoya Gluzman-Poltorak, Jacob Rosenberg
- Spotlight: Designing analytical comparability assessments for process and manufacturing changes 16:00–16:15 · Innovation in Gene Delivery — Peter Webster
- Fireside Chat: Designing early clinical trials that generate meaningful proof of concept 16:00–16:15 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Samar Mohanty, Zoya Gluzman-Poltorak
- Spotlight: Mastering the CGT supply chain: Starting materials, shelf life & the final mile 16:00–16:15 · Commercializing Advanced Therapies — Alexey Bersenev
- Innovation zone: Manufacturing, scaleup & COGs reduction 16:00–17:00 · Innovation Zone — Thomas Eaton, Mohammad Sayed
- The Big Debate: Modular or platform manufacturing technology – which will hold sway in cell & gene therapy over the coming decade? 16:00–16:45 · Phacilitate Stage
- Session 7: The more we learn the less we know. How can we leverage an increasingly high-resolution picture of viral vector quality to the benefit of gene therapy product consistency and safety? 16:00–17:00 · Innovation in Gene Delivery — Kyle Carter, Peter Webster
- Presentation 32 16:10–16:20 · Innovation Zone
- Spotlight 16:15–16:30 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept
- Spotlight: Automating the last mile: Tools that make point-of-care delivery scalable 16:15–16:30 · Commercializing Advanced Therapies — Bella Neufeld
- Spotlight/Fireside Chat 16:15–16:30 · Innovation in Gene Delivery
- Presentation 33 16:20–16:30 · Innovation Zone — Mohammad Sayed
- Panel: Executing early clinical trials efficiently. Overcoming operational barriers to proof of concept 16:30–17:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Jacob Rosenberg
- Presentation 34 16:30–16:40 · Innovation Zone
- Panel: Supply chain as a commercial strategy: The new determinant of market access 16:30–17:00 · Commercializing Advanced Therapies — Cristina Salado Manzano, Adi Braun, Louis Cicchini
- Panel discussion 16:30–17:00 · Innovation in Gene Delivery — Kyle Carter, Peter Webster
- Presentation 35 16:40–16:50 · Innovation Zone
- Presentation 36 16:50–17:00 · Innovation Zone
- WIAT Workshop 17:00–18:00 · Women in Advanced Therapies
Day 4 — Thursday 21 January 2027
- WIAT Breakfast 07:00–08:00 · Women in Advanced Therapies
- Spotlight: 09:00–09:15 · Commercializing Advanced Therapies — Jay Cuenca
- Session 6: Do we need to rethink our approach to overcoming resistance in the TME? 09:00–10:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Raphael Ognar, Aaron Edwards, Samik Basu
- Session 8: How and where is innovation in both systemic and local delivery enabling the migration of advanced therapies into emerging indications and therapeutic areas? 09:00–10:00 · Innovation in Gene Delivery — Sheena Smith, Michael Klichinsky
- Fireside Chat: Rethinking the solid tumor landscape: Reassessing the opportunities and challenges in solid tumors 09:00–09:15 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Samik Basu
- Spotlight 09:00–09:15 · Innovation in Gene Delivery — Michael Klichinsky
- Session 7: What does the future hold for allogeneic cell therapy? 09:00–10:00 · Commercializing Advanced Therapies — Ashish Saksule, Jay Cuenca, Rocio Manghani
- Spotlight/Fireside Chat 09:15–09:30 · Innovation in Gene Delivery
- Spotlight 09:15–09:30 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept
- Spotlight: Engineering the allogeneic edge: Safety, efficacy & scalability breakthroughs 09:15–09:30 · Commercializing Advanced Therapies
- Panel: Winning the allogeneic race: Commercial viability in a crowded modality landscape 09:30–10:00 · Commercializing Advanced Therapies — Ashish Saksule, Rocio Manghani
- Panel discussion 09:30–10:00 · Innovation in Gene Delivery — Sheena Smith
- Panel: Overcoming the tumor microenvironment: Which strategies hold the greatest promise for solid tumors? 09:30–10:00 · Streamlining Early Development to Enable Rapid Clinical Proof of Concept — Aaron Edwards
- Session 5: The Solution Sprint 10:00–11:00 · Empowering Patients, Delivering Access (in Partnership with the Emily Whitehead Foundation)
- Session 9: Next-generation vector systems and emerging payloads – how and where can they enable the cell & gene therapy field to advance? 10:00–11:00 · Innovation in Gene Delivery — Jeroen de Vrij, Mercedes Segura Gally, Sheena Smith, Nathalie Clément
- Session 8: How is the advanced therapies manufacturing and supply chain infrastructure evolving worldwide in support of global clinical development opportunities 10:00–11:00 · Manufacturing, CMC and Supply Chain — Gina Jiang, Kelsey Wakley-Sharman
- Fireside Chat: How to manufacture your biologics in China? Navigating the uncertainties 10:00–10:15 · Manufacturing, CMC and Supply Chain — Gina Jiang
- Spotlight: Engineering precision in vivo delivery with SHREAD adenoviral VLPs 10:00–10:15 · Innovation in Gene Delivery — Sheena Smith
- Session 8: Accelerated approval pathways: Do the benefits really outweigh the costs? 10:00–11:00 · Commercializing Advanced Therapies — Snehal Naik, Chris Juenger, Noelle Harff
- Spotlight/Fireside Chat 10:15–10:30 · Manufacturing, CMC and Supply Chain
- Spotlight/Fireside Chat 10:15–10:30 · Innovation in Gene Delivery
- Panel: Accelerated approval in 2026: A necessary tool or a commercial liability? 10:15–11:00 · Commercializing Advanced Therapies — Snehal Naik, Chris Juenger
- Panel discussion 10:30–11:00 · Manufacturing, CMC and Supply Chain — Kelsey Wakley-Sharman
- Panel discussion 10:30–11:00 · Innovation in Gene Delivery — Jeroen de Vrij, Mercedes Segura Gally, Nathalie Clément
- Closing plenary: Defining key takeaways and setting future goals/actions for all stakeholders in enabling improved patient access to cell & gene therapies 11:30–12:30
Organisers, sponsors and partners
Organiser (1)
Sponsors (36)
Vector BioMed · Ascend · Thermo Fisher · Lonza AG · Yoh Services LLC · SK pharmteco · Pluristyx, Inc. · Vitrafy Life Sciences Ltd · Cellular Origins Ltd · LumaCyte · Celleo Biotech Ltd · Astraveus · Emerson Electric Co. · Sartorius Stedim Biotech GmbH · Cryoport Systems · ProBio · KROMATID · CellBri US · Biomerieux · Cytiva · CORNING · Bio-Techne · Catalent Beauty · PQP Group · CleanSpace Technology · CRB · Biolife Solutions · VIVEbiotech · Aldevron · Charter Medical LLC · Invetech · Bionova Scientific · Xiogenix · ChemoMetec · Gift of Life Biologics · Adva Biotechnology
Media Partner (1)
Association Partners (2)
Biocom · California Life Sciences (CLS)
Exhibitors (26)
OriGen Biomedical · Tema Sinergie · Aspetic Technologies · American Red Cross Cell and Gene Therapy Solutions · Technoflex · Phacilitate · ImpactLife · Uniphar Pharma Solutions Limited · TrakCel · Watson-Marlow Fluid Technology Solutions · Kincellis · OXB (formerly Oxford Biomedica) · Bionique Testing Laboratories LLC · FUJIFILM Biotechnologies · CPC Biotech · Versiti Clinical Trial Solutions · STEMCELL Technologies · eXmoor Pharma · SaniSure Inc · CELLSCRIPT · Visicell Medical Inc. · CoJourney · AIT Ltd · CellStore Biotechnology Co., Ltd. · EF Healthcare · Distek, Inc
Supporting Partners (3)
Flemingsberg Science Foundation · Emily Whitehead Foundation · Enmore Bio
Source: the published agenda. See how B2DB compiles its records.